250610801
PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

Advertise on podcast: PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

Rating
★★★★★
4.5
from
10 reviews
This podcast has
624 episodes
Language
English
Date created
2007/03/29
Latest episode
2026/10/13
Average duration
51 min.
Release period
5 days

Description

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

Unlock PeerView Oncology & Hematology CME/CNE/CPE Video Podcast podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Social media

Check PeerView Oncology & Hematology CME/CNE/CPE Video Podcast social media presence


Podcast episodes

Check latest episodes from PeerView Oncology & Hematology CME/CNE/CPE Video Podcast podcast


Ghassan Abou-Alfa, MD, JD, MBA, PhD(hc) - Redefining Therapeutic Progress in HCC: Extending the Benefits of Immunotherapy to Earlier Stages of Disease
2026/10/13
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PEH865. CME/MOC/AAPA/IPCE credit will be available until July 16, 2027. Redefining Therapeutic Progress in HCC: Extending the Benefits of Immunotherapy to Earlier Stages of Disease In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an independent educational grant from AstraZeneca. Disclosure information is available at the beginning of the video presentation.
Nikhil I. Khushalani, MD - The Next Act of Immunotherapy in CSCC: Upgrading the Risk-Adapted Management of Resectable Disease
2026/10/09
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/DAP865. CME/MOC/AAPA/IPCE credit will be available until October 15, 2027. The Next Act of Immunotherapy in CSCC: Upgrading the Risk-Adapted Management of Resectable Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Society of Surgical Oncology. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. Disclosure information is available at the beginning of the video presentation.
Prof. David Planchard, MD, PhD - From Data to Decisions in HER2-Overexpressing NSCLC: Detecting Alterations, Implementing Therapeutic Advances, and Navigating Practicalities of Care
2026/10/09
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/EMJ865. CME/EBAC/AAPA/IPCE credit will be available until October 13, 2027. From Data to Decisions in HER2-Overexpressing NSCLC: Detecting Alterations, Implementing Therapeutic Advances, and Navigating Practicalities of Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an educational grant from Daiichi Sankyo, Inc. Disclosure information is available at the beginning of the video presentation.
Erika Hamilton, MD / Tiffany A. Traina, MD, FASCO - Practice Readiness for TROP2-Targeting ADCs in First-Line TNBC: Right Patient, Right Time, Right Team
2026/10/09
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NER865. CME/MOC/AAPA/IPCE credit will be available until September 24, 2027. Practice Readiness for TROP2-Targeting ADCs in First-Line TNBC: Right Patient, Right Time, Right Team In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc. Disclosure information is available at the beginning of the video presentation.
Stephen V. Liu, MD - Building a Better Backbone for NSCLC and SCLC Treatment With PD-(L)1xVEGF-A Bispecific Antibodies: Inducing Immune Invigoration, Simplifying Treatment Delivery, and Enhancing Clinical Outcomes
2026/10/09
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/XSQ865. CME/MOC/EBAC/NCPD/CPE/AAPA/IPCE credit will be available until October 12, 2027. Building a Better Backbone for NSCLC and SCLC Treatment With PD-(L)1xVEGF-A Bispecific Antibodies: Inducing Immune Invigoration, Simplifying Treatment Delivery, and Enhancing Clinical Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an educational grant from BioNTech and Bristol Myers Squibb. Disclosure information is available at the beginning of the video presentation.
Charise Gleason, MSN, NP-C, AOCNP - MoDernizing RRMM Care: Oncology Nurse Perspectives on CELMoD Strategies and Principles for Sequential Therapy
2026/10/05
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete NCPD information, and to apply for credit, please visit us at PeerView.com/ACX865. NCPD credit will be available until September 27, 2027. MoDernizing RRMM Care: Oncology Nurse Perspectives on CELMoD Strategies and Principles for Sequential Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported through an educational grant from Bristol Myers Squibb. Disclosure information is available at the beginning of the video presentation.
William G. Wierda, MD, PhD - C3–Changing Conversations on CLL: Evidence and Emerging Consensus on Targeted Agents Across Lines of Therapy
2026/10/05
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SNH865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until October 8, 2027. C3–Changing Conversations on CLL: Evidence and Emerging Consensus on Targeted Agents Across Lines of Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by independent educational grants from AstraZeneca, BeOne Medicines, and Lilly. Disclosure information is available at the beginning of the video presentation.
Jonathan L. Kaufman, MD - On Track for Remission in Multiple Myeloma: Modern Off-the-Shelf Choices for Effective and Accessible Care in Relapsed/Refractory Disease
2026/09/18
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CDJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until September 8, 2027. On Track for Remission in Multiple Myeloma: Modern Off-the-Shelf Choices for Effective and Accessible Care in Relapsed/Refractory Disease In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This educational activity is supported by an independent medical education grant from GSK. Disclosure information is available at the beginning of the video presentation.
Barrett Craig Lawson, MD, Joyce Liu, MD, MPH - Powering Pathology Precision: Expert Strategies for Folate Receptor Alpha Testing to Guide Personalized ADC Care in Advanced Ovarian Cancer
2026/09/10
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/FQR865. CME/MOC/CC/AAPA credit will be available until September 8, 2027. Powering Pathology Precision: Expert Strategies for Folate Receptor Alpha Testing to Guide Personalized ADC Care in Advanced Ovarian Cancer In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Ovarian Cancer Coalition. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an independent educational grant from AbbVie. Disclosure information is available at the beginning of the video presentation.
Nicholas M. Bernthal, MD, FAOA / Prof. Hans Gelderblom, MD - The ABCs of TGCT: Accurate Diagnosis, Understanding Patient Burden, and Coordinating Collaborative Multidisciplinary Care
2026/09/07
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/GGN865. CME credit will be available until September 2, 2027. The ABCs of TGCT: Accurate Diagnosis, Understanding Patient Burden, and Coordinating Collaborative Multidisciplinary Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Sarcoma Alliance for Research through Collaboration. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by independent educational grants from Deciphera Pharmaceuticals, a member of ONO Pharma, and Merck KGaA, Darmstadt, Germany. Disclosure information is available at the beginning of the video presentation.
Alicia K. Morgans, MD, MPH, FASCO, Matthew B. Rettig, MD - The March of Innovation in Prostate Cancer: Advancing Veteran Care With an Expanding and Personalized Treatment Arsenal
2026/08/31
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/FZW865. CME/MOC/AAPA/IPCE credit will be available until September 5, 2027. The March of Innovation in Prostate Cancer: Advancing Veteran Care With an Expanding and Personalized Treatment Arsenal In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Association of Veterans' Research and Education Foundations. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc. and Novartis Pharmaceuticals Corporation. Disclosure information is available at the beginning of the video presentation.
Brian Slomovitz, MD, MS, FACOG - Next-Generation Strategies in Advanced Ovarian Cancer: Are You Prepared to Harness Novel Mechanisms of Action and the Latest Therapeutic Innovations?
2026/08/24
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/JMM865. CME/MOC/NCPD/AAPA credit will be available until August 16, 2027. Next-Generation Strategies in Advanced Ovarian Cancer: Are You Prepared to Harness Novel Mechanisms of Action and the Latest Therapeutic Innovations? In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This educational activity is supported by independent medical education grants from Corcept Therapeutics, Inc. and Verastem Oncology. Disclosure information is available at the beginning of the video presentation.
Neal D. Shore, MD, FACS - Directing Better Outcomes in Prostate Cancer: Urologist Leadership in Personalizing Treatment Innovation and Delivering Patient-Centered Care
2026/08/24
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WDH865. CME/MOC/AAPA/IPCE credit will be available until August 16, 2027. Directing Better Outcomes in Prostate Cancer: Urologist Leadership in Personalizing Treatment Innovation and Delivering Patient-Centered Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by independent educational grants from AstraZeneca, Blue Earth Diagnostics, Johnson & Johnson and Novartis Pharmaceuticals Corporation. Disclosure information is available at the beginning of the video presentation.
Michael R. Grunwald, MD, FACP - The A-Factor in Myelofibrosis: Addressing Anemia and Prioritizing Personalized Team Management
2026/08/14
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/QFY865. CME/MOC/NCPD/AAPA/IPCE credit will be available until August 3, 2027. The A-Factor in Myelofibrosis: Addressing Anemia and Prioritizing Personalized Team Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This educational activity is supported by an independent medical education grant from GSK. Disclosure information is available at the beginning of the video presentation.
Associate Professor Jim Whittle, MBBS, PhD, FRACP / Katie Metrock, MD - Moving MEK Inhibitor Therapy FORWARD in NF1: A Neuro-Oncology FOrum on Real-World Application of Recent Data for Improving Patient Care
2026/08/04
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/SKY865. CME/AAPA credit will be available until July 28, 2027. Moving MEK Inhibitor Therapy FORWARD in NF1: A Neuro-Oncology FOrum on Real-World Application of Recent Data for Improving Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an independent medical education grant from SpringWorks, a healthcare company of Merck KGaA, Darmstadt, Germany. Disclosure information is available at the beginning of the video presentation.

Podcast reviews

Read PeerView Oncology & Hematology CME/CNE/CPE Video Podcast podcast reviews


4.5 out of 5
10 reviews

Podcast sponsorship advertising

Start advertising on PeerView Oncology & Hematology CME/CNE/CPE Video Podcast relevant audience podcasts


What do you want to promote?